Thankfully, one is not mutually exclusive of the other. Read more in our April column in Medical Product Outsourcing Magazine.

If you have good numbers you’ll get the attention of the PE firms at an excellent valuation (if you’re in MedTech). Catch the attention of a strategic and your numbers may get even a bit better!

A closer examination of some key orthopedic device industry battlegrounds.

We all assume if we’re in healthcare we all speak the same language and when it comes to using acronyms that we’re all on the same page with what they mean. Well, not always.

There are many key themes for C-Suite executives to consider in light of this year’s show.

A detailed examination of each major stakeholder in this modern industrial revolution in our inaugural column in Orthopedic Design & Technology Magazine.

Capitalizing on these opportunities will allow medtech organizations to continue to grow well into the future. Read more in our February column in MPO.

Improve your value proposition for today and tomorrow.

The FDA’s recent draft guidance on medical devices with software will require companies’ complete attention.

Scalability should be on top of the list of strategic topics regardless of a company’s size or stage.

The FTC and the EU’s scrutiny of healthcare/life sciences M&A plays a vital role in shaping the industry’s core markets.

In a world where Digital Health and AI are buzzwords: what happened to medical device manufacturing? Is it still a positive business to be in? What’s the long-term outlook? What’s the geopolitical climate for this type of manufacturing? Should I continue to invest and grow?

Major MedTech corporations often engage in acquisitions to drive their growth and market dominance.

Is Europe’s regulatory burden a loss for the EU and a gain for the U.S.?